Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

IMPORTANCE: Pregnant women are at increased risk of morbidity and mortality from COVID-19 but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety and immunogenicity in these populations are therefore limited. OBJECTIVE: To evaluate the immunogenicity of COVID-19 messe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA
Prif Awduron: Collier, Ai-ris Y., McMahan, Katherine, Yu, Jingyou, Tostanoski, Lisa H., Aguayo, Ricardo, Ansel, Jessica, Chandrashekar, Abishek, Patel, Shivani, Apraku Bondzie, Esther, Sellers, Daniel, Barrett, Julia, Sanborn, Owen, Wan, Huahua, Chang, Aiquan, Anioke, Tochi, Nkolola, Joseph, Bradshaw, Connor, Jacob-Dolan, Catherine, Feldman, Jared, Gebre, Makda, Borducchi, Erica N., Liu, Jinyan, Schmidt, Aaron G., Suscovich, Todd, Linde, Caitlyn, Alter, Galit, Hacker, Michele R., Barouch, Dan H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2021
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120446/
https://ncbi.nlm.nih.gov/pubmed/33983379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.7563
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg